GlaxoSmithKline Awarded $342,000,000 Contract for COVID-19 Vaccines
GlaxoSmithKline LLC, Research Triangle Park, North Carolina, was awarded a $342,000,000 firm-fixed-price contract to procure mass quantities of COVID-19 vaccines from multiple vendors to support military locations and personnel throughout the continental U.S. and outside the continental U.S.
Bids were solicited via the internet with one received. Work will be performed in Research Triangle Park, North Carolina, with an estimated completion date of Feb. 28, 2021. Fiscal 2020 research, development, test and evaluation (Army) funds in the amount of $342,000,000 were obligated at the time of the award. U.S. Army Contracting Command, Newark, New Jersey, is the contracting activity (W15QKN-20-C-0048).